MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

NeoGenomics Inc

Suletud

10.05 1.72

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

9.7

Max

10.13

Põhinäitajad

By Trading Economics

Sissetulek

2.4M

-15M

Müük

4.2M

172M

Aktsiakasum

0.04

Kasumimarginaal

-8.909

Töötajad

2,200

EBITDA

1.9M

3.7M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+66.3% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

29. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-360M

1.2B

Eelmine avamishind

8.33

Eelmine sulgemishind

10.05

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. apr 2025, 15:50 UTC

Omandamised, ülevõtmised, äriostud

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One -- Update

23. apr 2025, 14:29 UTC

Omandamised, ülevõtmised, äriostud

Cantor Agrees to $3.6 Billion SPAC Deal With Crypto Company Twenty One

16. apr 2025, 15:17 UTC

Suurimad hinnamuutused turgudel

Janover Shares Drop After Partnership Plans With Crypto Exchange

10. apr 2025, 15:12 UTC

Suurimad hinnamuutused turgudel

Janover Shares Rise After Company Begins Solana Purchases

24. apr 2025, 11:49 UTC

Market Talk

Bitcoin Eases After Recent Risk-On Rally -- Market Talk

23. apr 2025, 15:35 UTC

Omandamised, ülevõtmised, äriostud

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One -- Update

23. apr 2025, 14:14 UTC

Omandamised, ülevõtmised, äriostud

Cantor Agrees to $3.6B SPAC Deal With Crypto Company Twenty One

23. apr 2025, 09:17 UTC

Peamised uudised

Bitcoin Price Rises Above $94,000 -- WSJ

23. apr 2025, 09:04 UTC

Peamised uudised

Bitcoin Price Rallies. Why Trump, Fed and China Are Boosting the Crypto. -- Barrons.com

23. apr 2025, 08:37 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

23. apr 2025, 08:37 UTC

Market Talk

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Trade War -- Market Talk

23. apr 2025, 01:00 UTC

Peamised uudised

'I Could Lose It All Tomorrow': The Traders Leaning In to Wild Markets -- WSJ

22. apr 2025, 13:58 UTC

Market Talk

Fed Independence Concerns Could Lift Bitcoin to Record High -- Market Talk

22. apr 2025, 08:47 UTC

Market Talk

Bitcoin Rises as Investors Seek Dollar Alternatives -- Market Talk

21. apr 2025, 14:28 UTC

Peamised uudised

Bitcoin Rises. Tariffs, the Dollar, and What Else Is Boosting Crypto Prices. -- Barrons.com

21. apr 2025, 14:01 UTC

Omandamised, ülevõtmised, äriostud

MicroStrategy Stock Is Rising on Latest $556 Million Bitcoin Purchase -- Barrons.com

21. apr 2025, 09:30 UTC

Peamised uudised

Crypto Knocks on the Door of a Banking World That Shut It Out -- WSJ

21. apr 2025, 09:04 UTC

Peamised uudised

Bitcoin and Other Crypto Prices Rise. It's All Linked to Dollar Weakness. -- Barrons.com

17. apr 2025, 14:03 UTC

Market Talk

ECB's Lagarde Welcomes Review of Stablecoin Regulation -- Market Talk

17. apr 2025, 14:01 UTC

Market Talk

ECB's Lagarde Highlights Digital Euro Efforts -- Market Talk

17. apr 2025, 09:48 UTC

Market Talk

Bitcoin Struggles to Rise Meaningfully After Trade News, Powell Remarks -- Market Talk

16. apr 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

16. apr 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

16. apr 2025, 16:09 UTC

Market Talk

Crypto Trading Demand Lower Than Expected, Interactive Brokers CEO Says -- Market Talk

15. apr 2025, 08:33 UTC

Market Talk

Bitcoin Edges Higher Amid Optimism Over Tariff Exemptions -- Market Talk

14. apr 2025, 15:52 UTC

Omandamised, ülevõtmised, äriostud

MicroStrategy Stock Rises. It Expands Bitcoin Holdings With $286 Million Purchase. -- Barrons.com

14. apr 2025, 14:10 UTC

Omandamised, ülevõtmised, äriostud

MicroStrategy Stock Rises. It Expands Bitcoin Holdings With $286 Million Purchase. -- Barrons.com

14. apr 2025, 08:41 UTC

Peamised uudised

Bitcoin, XRP, Ether Prices Mixed Amid Tariff Turmoil. Watch This Key Crypto Level. -- Barrons.com

10. apr 2025, 11:37 UTC

Market Talk

Bitcoin Falls After Brief Boost From Tariff Delay -- Market Talk

9. apr 2025, 10:51 UTC

Market Talk

Bitcoin Struggles to Recover Meaningfully as Tariff Worries Cap Gains -- Market Talk

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

66.3% tõus

12 kuu keskmine prognoos

Keskmine 16.78 USD  66.3%

Kõrge 19 USD

Madal 12 USD

Põhineb 14 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

10

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

9.56 / 10.44Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.